ID   KNG1_RAT                Reviewed;         639 AA.
AC   P08934; P08933;
DT   01-NOV-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1988, sequence version 1.
DT   24-JUL-2024, entry version 161.
DE   RecName: Full=Kininogen-1;
DE   Contains:
DE     RecName: Full=Kininogen-1 heavy chain;
DE   Contains:
DE     RecName: Full=Bradykinin;
DE   Contains:
DE     RecName: Full=Kininogen-1 light chain;
DE   Flags: Precursor;
GN   Name=Kng1; Synonyms=Kng;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS HMW AND LMW).
RX   PubMed=3029068; DOI=10.1016/s0021-9258(18)61638-2;
RA   Kitagawa H., Kitamura N., Hayashida H., Miyata T., Nakanishi S.;
RT   "Differing expression patterns and evolution of the rat kininogen gene
RT   family.";
RL   J. Biol. Chem. 262:2190-2198(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LMW).
RX   PubMed=2413018; DOI=10.1016/s0021-9258(17)38984-6;
RA   Furuto-Kato S., Matsumoto A., Kitamura N., Nakanishi S.;
RT   "Primary structures of the mRNAs encoding the rat precursors for bradykinin
RT   and T-kinin. Structural relationship of kininogens with major acute phase
RT   protein and alpha 1-cysteine proteinase inhibitor.";
RL   J. Biol. Chem. 260:12054-12059(1985).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-65.
RC   STRAIN=Buffalo;
RX   PubMed=2439509; DOI=10.1016/s0021-9258(18)48080-5;
RA   Fung W.-P., Schreiber G.;
RT   "Structure and expression of the genes for major acute phase alpha 1-
RT   protein (thiostatin) and kininogen in the rat.";
RL   J. Biol. Chem. 262:9298-9308(1987).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-41.
RC   STRAIN=Wistar; TISSUE=Liver;
RX   PubMed=3818598; DOI=10.1016/s0021-9258(18)61660-6;
RA   Kageyama R., Kitamura N., Ohkubo H., Nakanishi S.;
RT   "Differing utilization of homologous transcription initiation sites of rat
RT   K and T kininogen genes under inflammation condition.";
RL   J. Biol. Chem. 262:2345-2351(1987).
CC   -!- FUNCTION: Kininogens are inhibitors of thiol proteases. HMW-kininogen
CC       plays an important role in blood coagulation by helping to position
CC       optimally prekallikrein and factor XI next to factor XII; HMW-kininogen
CC       inhibits the thrombin- and plasmin-induced aggregation of thrombocytes.
CC       LMW-kininogen inhibits the aggregation of thrombocytes. LMW-kininogen
CC       is in contrast to HMW-kininogen not involved in blood clotting.
CC   -!- FUNCTION: [Bradykinin]: The active peptide bradykinin is a potent
CC       vasodilatator that is released from HMW-kininogen shows a variety of
CC       physiological effects: (A) influence in smooth muscle contraction, (B)
CC       induction of hypotension, (C) natriuresis and diuresis, (D) decrease in
CC       blood glucose level, (E) it is a mediator of inflammation and causes
CC       (E1) increase in vascular permeability, (E2) stimulation of nociceptors
CC       (4E3) release of other mediators of inflammation (e.g. prostaglandins),
CC       (F) it has a cardioprotective effect (directly via bradykinin action,
CC       indirectly via endothelium-derived relaxing factor action).
CC       {ECO:0000250|UniProtKB:P01042}.
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=HMW;
CC         IsoId=P08934-1; Sequence=Displayed;
CC       Name=LMW;
CC         IsoId=P08934-2; Sequence=VSP_001265, VSP_001266;
CC   -!- TISSUE SPECIFICITY: Plasma.
CC   -!- PTM: Bradykinin is released from kininogen by plasma kallikrein.
CC   -!- PTM: Phosphorylated by FAM20C in the extracellular medium.
CC       {ECO:0000250|UniProtKB:P01042}.
CC   -!- PTM: [Bradykinin]: Bradykinin is inactivated by ACE, which removes the
CC       dipeptide Arg-Phe from its C-terminus. {ECO:0000250|UniProtKB:P01042}.
CC   -!- MISCELLANEOUS: Rats express four types of kininogens: the classical
CC       HMW/LMW kininogens and two additional LMW-like kininogens: T-I and T-
CC       II.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L29428; AAA41486.1; -; mRNA.
DR   EMBL; M11884; AAA41487.1; -; mRNA.
DR   EMBL; M14369; AAA41484.1; -; Genomic_DNA.
DR   EMBL; M14369; AAA41485.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; M16455; AAA41482.1; -; Genomic_DNA.
DR   PIR; A25486; A25486.
DR   PIR; A28055; A28055.
DR   PIR; C25486; C25486.
DR   RefSeq; NP_036873.1; NM_012741.1. [P08934-1]
DR   AlphaFoldDB; P08934; -.
DR   SMR; P08934; -.
DR   IntAct; P08934; 1.
DR   STRING; 10116.ENSRNOP00000069578; -.
DR   MEROPS; I25.018; -.
DR   MEROPS; I25.019; -.
DR   MEROPS; I25.950; -.
DR   GlyCosmos; P08934; 5 sites, No reported glycans.
DR   GlyGen; P08934; 5 sites.
DR   PhosphoSitePlus; P08934; -.
DR   jPOST; P08934; -.
DR   PaxDb; 10116-ENSRNOP00000065146; -.
DR   GeneID; 25087; -.
DR   KEGG; rno:25087; -.
DR   UCSC; RGD:2980; rat. [P08934-1]
DR   AGR; RGD:1594590; -.
DR   CTD; 25087; -.
DR   RGD; 2980; Kng1.
DR   eggNOG; ENOG502RYAC; Eukaryota.
DR   InParanoid; P08934; -.
DR   OrthoDB; 5223498at2759; -.
DR   Reactome; R-RNO-114608; Platelet degranulation.
DR   Reactome; R-RNO-140837; Intrinsic Pathway of Fibrin Clot Formation.
DR   Reactome; R-RNO-375276; Peptide ligand-binding receptors.
DR   Reactome; R-RNO-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs).
DR   Reactome; R-RNO-416476; G alpha (q) signalling events.
DR   Reactome; R-RNO-418594; G alpha (i) signalling events.
DR   Reactome; R-RNO-8957275; Post-translational protein phosphorylation.
DR   PRO; PR:P08934; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005576; C:extracellular region; IBA:GO_Central.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0043204; C:perikaryon; IDA:RGD.
DR   GO; GO:0004869; F:cysteine-type endopeptidase inhibitor activity; IDA:RGD.
DR   GO; GO:0002020; F:protease binding; IPI:RGD.
DR   GO; GO:0007596; P:blood coagulation; IEA:UniProtKB-KW.
DR   GO; GO:0002542; P:Factor XII activation; IDA:RGD.
DR   GO; GO:0030195; P:negative regulation of blood coagulation; IBA:GO_Central.
DR   GO; GO:0050672; P:negative regulation of lymphocyte proliferation; IDA:RGD.
DR   GO; GO:0045861; P:negative regulation of proteolysis; IDA:RGD.
DR   GO; GO:0042130; P:negative regulation of T cell proliferation; IDA:RGD.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IBA:GO_Central.
DR   GO; GO:0001938; P:positive regulation of endothelial cell proliferation; IDA:RGD.
DR   GO; GO:0048146; P:positive regulation of fibroblast proliferation; IDA:RGD.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; IDA:RGD.
DR   GO; GO:0042311; P:vasodilation; IEA:UniProtKB-KW.
DR   CDD; cd00042; CY; 3.
DR   Gene3D; 3.10.450.10; -; 3.
DR   InterPro; IPR000010; Cystatin_dom.
DR   InterPro; IPR046350; Cystatin_sf.
DR   InterPro; IPR002395; Kininogen.
DR   InterPro; IPR027358; Kininogen-type_cystatin_dom.
DR   InterPro; IPR050735; Kininogen_Fetuin_HRG.
DR   InterPro; IPR018073; Prot_inh_cystat_CS.
DR   PANTHER; PTHR13814; FETUIN; 1.
DR   PANTHER; PTHR13814:SF12; KININOGEN-1; 1.
DR   Pfam; PF00031; Cystatin; 3.
DR   PRINTS; PR00334; KININOGEN.
DR   SMART; SM00043; CY; 3.
DR   SUPFAM; SSF54403; Cystatin/monellin; 3.
DR   PROSITE; PS00287; CYSTATIN; 2.
DR   PROSITE; PS51647; CYSTATIN_KININOGEN; 3.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Blood coagulation; Disulfide bond; Glycoprotein;
KW   Hemostasis; Inflammatory response; Phosphoprotein; Protease inhibitor;
KW   Reference proteome; Repeat; Secreted; Signal; Thiol protease inhibitor;
KW   Vasoactive; Vasodilator.
FT   SIGNAL          1..18
FT   CHAIN           19..639
FT                   /note="Kininogen-1"
FT                   /id="PRO_0000006695"
FT   CHAIN           19..380
FT                   /note="Kininogen-1 heavy chain"
FT                   /id="PRO_0000006696"
FT   PEPTIDE         381..389
FT                   /note="Bradykinin"
FT                   /id="PRO_0000006697"
FT   CHAIN           390..639
FT                   /note="Kininogen-1 light chain"
FT                   /id="PRO_0000006698"
FT   DOMAIN          28..132
FT                   /note="Cystatin kininogen-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00979"
FT   DOMAIN          151..254
FT                   /note="Cystatin kininogen-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00979"
FT   DOMAIN          273..376
FT                   /note="Cystatin kininogen-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00979"
FT   REGION          438..462
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          476..547
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        438..459
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        484..500
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        501..516
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        517..543
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            387..388
FT                   /note="Cleavage; by ACE"
FT                   /evidence="ECO:0000250|UniProtKB:P01042"
FT   MOD_RES         332
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P01042"
FT   CARBOHYD        82
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        169
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        205
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        294
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        529
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        28..609
FT                   /note="Interchain (between heavy and light chains)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00979"
FT   DISULFID        83..94
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00979"
FT   DISULFID        107..126
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00979"
FT   DISULFID        142..145
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00979"
FT   DISULFID        206..218
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00979"
FT   DISULFID        229..248
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00979"
FT   DISULFID        264..267
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00979"
FT   DISULFID        328..340
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00979"
FT   DISULFID        351..370
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00979"
FT   VAR_SEQ         402..433
FT                   /note="VSPSYIARVQEERDPGNEQGPIHGHGWLHAKQ -> RLLNSCEYKGRLLKAG
FT                   AGPAPERQAEASTVTP (in isoform LMW)"
FT                   /evidence="ECO:0000303|PubMed:2413018,
FT                   ECO:0000303|PubMed:3029068"
FT                   /id="VSP_001265"
FT   VAR_SEQ         434..639
FT                   /note="Missing (in isoform LMW)"
FT                   /evidence="ECO:0000303|PubMed:2413018,
FT                   ECO:0000303|PubMed:3029068"
FT                   /id="VSP_001266"
FT   CONFLICT        61
FT                   /note="E -> K (in Ref. 2)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   639 AA;  70933 MW;  D3172DF94FF56AF5 CRC64;
     MKLITILLLC SRLLPSLAQE EDAQEMDCND ESLFQAVDTA LKKYNAGLKS GNQFVLYQVT
     EGTKKDGSKT FYSFKYQIKE GNCSVQSGFA WQDCDFKDAE EAATGECTAT LEKRRNNKFS
     IATQICNITP GKGPIVTNEY HCLGCMHPIS VDSPELGPVL KHAVEHFNNN TKHTHLFALG
     EVKSADRQVV AGMNYQIIYS IVQTNCSKED FPSLHEDCVP LPSGDDGECK GNAFVDIHKT
     IAGFSDSCEF YPGDDLFELL PEDCPGCPRN IPVDSPELKE ALGHSIAQLN AENNHTFYFK
     IDTVKKATSQ VVAGTKYVIE FIARETKCSK ESNAELTADC ETKRLGQSLN CNANVYMRPW
     ENKVVPTVKC KVLDMTSVIR RPPGFSPFRA PRVKKPKEST TVSPSYIARV QEERDPGNEQ
     GPIHGHGWLH AKQIKNKNHQ GHKHGHGIGH GHQKPHGLGH GHQLKLDDLK QQREDGYDHR
     HPVGHGHGQR HGHGHGHGHG RDKHTNKDKN NVKHTDQRRA PLTSSSEDNT TSTQIQGRTE
     GFTLNPPLAQ PAVISRGFQD SGFTEGVIAT TSPYDTETHD DLIPDIHVQP DSLSFKLISD
     FPEATSHKCP GRPWKPVSRK DPTIETTEFS DFDLLDALS
//
